Drug General Information
Drug ID
D0X6QL
Former ID
DIB018014
Drug Name
KGP94
Drug Type
Small molecular drug
Indication Coagulation [ICD10:I80-I82] Clinical trial [541661]
Structure
Download
2D MOL
Formula
C14H12BrN3OS
InChI
InChI=1S/C14H12BrN3OS/c15-11-5-1-3-9(7-11)13(17-18-14(16)20)10-4-2-6-12(19)8-10/h1-8,19H,(H3,16,18,20)/b17-13-
InChIKey
ZDBKSZKTCPOBFR-LGMDPLHJSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Cathepsin L Target Info Inhibitor [531200]
KEGG Pathway Lysosome
Phagosome
Antigen processing and presentation
Proteoglycans in cancer
Rheumatoid arthritis
NetPath Pathway IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
Reactome Endosomal/Vacuolar pathway
Collagen degradation
Degradation of the extracellular matrix
Trafficking and processing of endosomal TLR
Assembly of collagen fibrils and other multimeric structures
MHC class II antigen presentation
WikiPathways Primary Focal Segmental Glomerulosclerosis FSGS
References
Ref 541661(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6533).
Ref 531200Bioorg Med Chem Lett. 2010 Nov 15;20(22):6610-5. Epub 2010 Sep 15.Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.

If you find any error in data or bug in web service, please kindly report it to Dr. Wang and Dr. Li.